These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 25987178)
61. Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation. Kapaun P; Dittmann RW; Granitzny B; Eickhoff W; Wulbrand H; Neumaier-Probst E; Zander A; Kohlschüetter A J Child Neurol; 1999 Apr; 14(4):222-8. PubMed ID: 10334395 [TBL] [Abstract][Full Text] [Related]
62. Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation; a 4-year follow-up study. Navarro C; Fernández JM; Domínguez C; Fachal C; Alvarez M Neurology; 1996 Jan; 46(1):254-6. PubMed ID: 8559389 [TBL] [Abstract][Full Text] [Related]
63. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Hyde TM; Ziegler JC; Weinberger DR Arch Neurol; 1992 Apr; 49(4):401-6. PubMed ID: 1532712 [TBL] [Abstract][Full Text] [Related]
64. Co-occurrence of Metachromatic Leukodystrophy in Phelan-McDermid Syndrome. Mingbunjerdsuk D; Wong M; Bozarth X; Sun A J Child Neurol; 2021 Feb; 36(2):148-151. PubMed ID: 32991243 [TBL] [Abstract][Full Text] [Related]
65. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy. Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587 [TBL] [Abstract][Full Text] [Related]
67. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Martin HR; Poe MD; Provenzale JM; Kurtzberg J; Mendizabal A; Escolar ML Biol Blood Marrow Transplant; 2013 Apr; 19(4):616-24. PubMed ID: 23348427 [TBL] [Abstract][Full Text] [Related]
68. Molecular basis of different forms of metachromatic leukodystrophy. Polten A; Fluharty AL; Fluharty CB; Kappler J; von Figura K; Gieselmann V N Engl J Med; 1991 Jan; 324(1):18-22. PubMed ID: 1670590 [TBL] [Abstract][Full Text] [Related]
69. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507 [TBL] [Abstract][Full Text] [Related]
71. Gene Therapy for Rare Central Nervous System Diseases Comes to Age. Aubourg P Endocr Dev; 2016; 30():141-6. PubMed ID: 26684481 [TBL] [Abstract][Full Text] [Related]
72. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations. Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723 [TBL] [Abstract][Full Text] [Related]
73. Bone marrow transplantation in metachromatic leukodystrophy caused by saposin-B deficiency: a case report with a 3-year follow-up period. Landrieu P; Blanche S; Vanier MT; Metral S; Husson B; Sandhoff K; Fischer A J Pediatr; 1998 Jul; 133(1):129-32. PubMed ID: 9672525 [TBL] [Abstract][Full Text] [Related]
74. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092 [TBL] [Abstract][Full Text] [Related]
75. Metachromatic leukodystrophy: an overview of current and prospective treatments. Biffi A; Lucchini G; Rovelli A; Sessa M Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S2-6. PubMed ID: 18978739 [TBL] [Abstract][Full Text] [Related]
76. [Molecular screening of the major mutations in the ARSA gene in patients with metachromatic leukodystrophy]. Horovenko NH; Ol'khovych NV; Pichkur NO Tsitol Genet; 2002; 36(5):43-8. PubMed ID: 12442547 [TBL] [Abstract][Full Text] [Related]
77. The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review. Chang SC; Eichinger CS; Field P Eur J Med Res; 2024 Mar; 29(1):181. PubMed ID: 38494502 [TBL] [Abstract][Full Text] [Related]
78. Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy. Calbi V; Fumagalli F; Consiglieri G; Penati R; Acquati S; Redaelli D; Attanasio V; Marcella F; Cicalese MP; Migliavacca M; Barzaghi F; Ferrua F; Assanelli A; Silvani P; Zoccolillo M; Chidini G; Chiesa R; Arora R; Ciotti F; Sarzana M; Antonioli G; Baldoli C; Morena F; Martino S; Ardissino GL; Sora MGN; Naldini L; Ciceri F; Aiuti A; Bernardo ME Bone Marrow Transplant; 2018 Jul; 53(7):913-917. PubMed ID: 29379168 [No Abstract] [Full Text] [Related]
79. Pathology of the gallbladder in a child with metachromatic leukodystrophy. McFadden K; Ranganathan S Pediatr Dev Pathol; 2015; 18(3):228-30. PubMed ID: 25569213 [TBL] [Abstract][Full Text] [Related]
80. Identification of a novel splicing mutation in the ARSA gene in a patient with late-infantile form of metachromatic leukodystrophy. Kang DH; Lee DH; Hong YH; Lee ST; Jeon BR; Lee YK; Ki CS; Lee YW Korean J Lab Med; 2010 Oct; 30(5):516-20. PubMed ID: 20890085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]